Cell & Gene Therapy Development & Manufacturing
The Biopharma Division at NJII was established to help our partners in the industry overcome challenges they face as they develop the next wave of cell and gene therapies.
We have a multi-million dollar, state-of-the-art Cell and Gene Therapy Development Center name BioCentriq which is used for flexible process development and clinical manufacturing.
We are designed to help you move from bench to scale. Our goal is to help you scale your production capabilities and advance your products from the lab to the clinic.
Our mission is to support industry-wide advancement, so we also focus on workforce development and the incubation of promising start-ups.
Why Choose Us?
Fast and Cost
Effective
Secure and
Confidential
Broad
Expertise
Flexibility &
Customization
See Our Facility
Watch the BioCentriq Video
BioCentriq, our state-of-the-art process development and cGMP manufacturing center features two GMP suites for clinical production of cell & gene therapies and a process development pilot plant.
Our clients come to us for fast and cost effective development services that are secure, confidential and flexible. We do not retain any intellectual property, and work with our clients to customize a development process that is right for them.
Our Industry Partners
Meet The Team
Haro
Hartounian, Ph.D.
Senior Vice President & General Manager
Hanna
Ioannidis, Ph.D.
Director, Alliance & Project Management
Chathuranga
De Silva, Ph.D.
Director, Business Development
Sadiq
Khan, MBA
Senior Director, Planning & Operations
Fuhua
Xu, Ph.D.
Principal Scientist
Bhumesh
Savalia, M.Sc.
Principal Scientist
Zainab
Alali, Ph.D.
Director, Quality & Compliance
Jorge
Santiago-Ortiz, Ph.D.
Director, Process Development
Alex
Klarer
Head of Cell Therapy
Rucheet
Patel, M.Sc.
Project Manager
Dagmar
Meissner, M.Sc.
CMC Consultant
Mayank
Patel
Consultant
Amir
Varkouhi, MD, Ph.D.
Senior Research Fellow
John
Yarotsky, Ph.D.
Senior Research Fellow